Evidence map›Paper›PMID 35771027›Full record

ArticleJournal of diabetes science and technology2024

Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children.

Ana Lúcia Domingues Neves, Luiz Eduardo Galvão Martins, Mônica Andrade Lima Gabbay, Gabriela Cavicchioli, Fernanda Silva Tenorio, Tatiana Sousa Cunha

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Lúcia Domingues NevesPostgraduate Program in Translational Medicine, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo, São Paulo/SP, Brazil.ORCID 0000-0001-5172-0428
Luiz Eduardo Galvão MartinsInstitute of Science and Technology, Federal University of São Paulo, São Paulo/SP, Brazil.
Mônica Andrade Lima GabbayDepartment of Medicine, Paulista School of Medicine, Federal University of São Paulo, São Paulo/SP, Brazil.
Gabriela CavicchioliAmbulatory of Insulin Infusion Pump from the Federal University of São Paulo Diabetes Center, Sao Paulo/SP, Brazil.
Fernanda Silva TenorioPostgraduate Program in Translational Medicine, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo, São Paulo/SP, Brazil.
Tatiana Sousa CunhaInstitute of Science and Technology, Federal University of São Paulo, São Paulo/SP, Brazil.ORCID 0000-0001-9070-1414
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince the introduction of continuous subcutaneous insulin infusion (CSII), the benefits have been numerous. However, adverse events (AEs) are experienced by up to 40% of users per year, exposing them to potentially fatal risks. The available evidence on the variables that trigger AEs associated with CSII remains limited, indicating the importance of studies on the subject.

aimTo propose a taxonomy based on the prevalent AEs experienced by patients from a reference diabetes mellitus (DM) center in Brazil using different CSII devices.

methods118 patients participated in an online interview and answered the questions of the data collection instrument. Identifying categories and subcategories of analysis contributed to constructing the AEs taxonomy.

resultsThe five analysis categories identified were: CSII User Interface (n = 45), CSII Alert System (n = 13), CSII Software and Connection (n = 11), CSII Durability (n = 30), and Electrical and Mechanical System of CSII (n = 60) A total of 159 AEs were identified, including conflicting alert messages and error/warning notification failures, errors resulting from engine malfunctions, data loss, patient interface deficiencies, button problems, and battery failure.

conclusionsThe study describes in a taxonomic format the AEs directly associated with the use of modern CSIIs that may contribute with additional information to the Food and Drug Administration (FDA) Medical Device Report (MDR) adverse event codes. In addition to guiding educational actions in the treatment of DM and providing information for health professionals and medical device developers, prospective studies examining the frequency of such problems, including the potential psychosocial impact of this technologically advanced therapy, are needed.

Indexed as

Diabetes Mellitus, Type 1Hypoglycemic AgentsAdolescentAdultBrazilChildEquipment FailureHumansInjections, SubcutaneousInsulinInsulin Infusion SystemsProspective StudiesHypoglycemic AgentsInsulincontinuous subcutaneous insulin infusioninsulin infusion systemssafetytaxonomytechnologytype 1 diabetes mellitus

Identifiers

PMID35771027
PMCPMC10899856
OpenAlexW4283718452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.